Kiniksa Pharmaceuticals Ltd (NASDAQ:KNSA) has announced a global license agreement with Roche Holdings AG (OTC:RHHBY) and Genentech to develop and commercialize vixarelimab, a fully human…
Advanced Micro Devices, Inc. (NASDAQ: AMD) shares were falling after-hours Tuesday in the wake of a second-quarter report that exceeded estimates — and a below-consensus third-quarter revenue forecast.
We expect muted top-line growth in the second half of 2022. Our Q3 Total Revenue outlook of $790 to $800 million is essentially flat year-over-year. We expect FX to have an 8-point impact on year-over-year revenue growth
KBR, Inc. (NYSE:KBR) reported second-quarter revenue growth of 5.2% year-over-year to $1.62 billion, missing the consensus of $1.63 billion. Adjusted EPS…